Nykode Therapeutics Announces FDA Approval of IND for VB-C-04, a Trial of VB10.16 in ...
FDA approval of IND for VB-C-04 trial.Nykode to further elaborate on trial design and development strategy at upcoming capital markets day in New York on September 20.